Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016;91(3):386–96. https://doi.org/10.1016/j.mayocp.2015.12.017.

Article  PubMed  Google Scholar 

Chow LQM. Head and neck cancer. N Engl J Med. 2020;382(1):60–72. https://doi.org/10.1056/NEJMra1715715.

Article  CAS  PubMed  Google Scholar 

Zhu X, Zhou J, Zhou L, Zhang M, Gao C, Tao L. Association between postoperative radiotherapy for young-onset head and neck cancer and long-term risk of second primary malignancy: a population-based study. J Transl Med. 2022;20(1):405. https://doi.org/10.1186/s12967-022-03544-y.

Article  PubMed  PubMed Central  Google Scholar 

Choi JH, Lee BS, Jang JY, Lee YS, Kim HJ, Roh J, et al. Single-cell transcriptome profiling of the stepwise progression of head and neck cancer. Nat Commun. 2023;14(1):1055. https://doi.org/10.1038/s41467-023-36691-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang X, Muzaffar J, Kirtane K, Song F, Johnson M, Schell MJ, et al. T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma. J Immunother Cancer. 2022;10(6): e004512. https://doi.org/10.1136/jitc-2022-004512.

Article  PubMed  PubMed Central  Google Scholar 

Ruffin AT, Li H, Vujanovic L, Zandberg DP, Ferris RL, Bruno TC. Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment. Nat Rev Cancer. 2023;23(3):173–88. https://doi.org/10.1038/s41568-022-00531-9.

Article  CAS  PubMed  Google Scholar 

Tang D, Zhang D, Heng Y, Zhu XK, Lin HQ, Zhou J, et al. Tumor-infiltrating PD-L1+ neutrophils induced by GM-CSF suppress T cell function in laryngeal squamous cell carcinoma and predict unfavorable prognosis. J Inflamm Res. 2022;15:1079–97. https://doi.org/10.2147/JIR.S347777.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Q, Hsueh CY, Shen YJ, Guo Y, Huang JM, Zhang YF, et al. Small extracellular vesicle-packaged TGFβ1 promotes the reprogramming of normal fibroblasts into cancer-associated fibroblasts by regulating fibronectin in head and neck squamous cell carcinoma. Cancer Lett. 2021;517:1–13. https://doi.org/10.1016/j.canlet.2021.05.017.

Article  CAS  PubMed  Google Scholar 

Ferris RL, Licitra L. PD-1 immunotherapy for recurrent or metastatic HNSCC. Lancet. 2019;394(10212):1882–4. https://doi.org/10.1016/S0140-6736(19)32539-5.

Article  PubMed  Google Scholar 

Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro JG, et al. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet. 2019;394(10212):1915–28. https://doi.org/10.1016/S0140-6736(19)32591-7.

Article  CAS  PubMed  Google Scholar 

Heng Y, Zhu X, Lin H, Jingyu M, Ding X, Tao L, et al. CD206+ tumor-associated macrophages interact with CD4+ tumor-infiltrating lymphocytes and predict adverse patient outcome in human laryngeal squamous cell carcinoma. J Transl Med. 2023;21(1):167. https://doi.org/10.1186/s12967-023-03910-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer. 2006;42(6):717–27. https://doi.org/10.1016/j.ejca.2006.01.003.

Article  CAS  PubMed  Google Scholar 

Zhang D, Tang D, Heng Y, Zhu XK, Zhou L, Tao L, et al. Prognostic impact of tumor-infiltrating lymphocytes in laryngeal squamous cell carcinoma patients. Laryngoscope. 2021;131(4):E1249–55. https://doi.org/10.1002/lary.29196.

Article  CAS  PubMed  Google Scholar 

Valero C, Pardo L, López M, García J, Camacho M, Quer M, et al. Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer. Head Neck. 2017;39(2):219–26. https://doi.org/10.1002/hed.24561.

Article  PubMed  Google Scholar 

Rosculet N, Zhou XC, Ha P, Tang M, Levine MA, Neuner G, et al. Neutrophil-to-lymphocyte ratio: prognostic indicator for head and neck squamous cell carcinoma. Head Neck. 2017;39(4):662–7. https://doi.org/10.1002/hed.24658.

Article  PubMed  Google Scholar 

Ponzetta A, Carriero R, Carnevale S, Barbagallo M, Molgora M, Perucchini C, et al. Neutrophils driving unconventional T cells mediate resistance against murine sarcomas and selected human tumors. Cell. 2019;178(2):346-360.e24. https://doi.org/10.1016/j.cell.2019.05.047.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hedrick CC, Malanchi I. Neutrophils in cancer: heterogeneous and multifaceted. Nat Rev Immunol. 2022;22(3):173–87. https://doi.org/10.1038/s41577-021-00571-6.

Article  CAS  PubMed  Google Scholar 

Antonio N, Bønnelykke-Behrndtz ML, Ward LC, Collin J, Christensen IJ, Steiniche T, et al. The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer. EMBO J. 2015;34(17):2219–36. https://doi.org/10.15252/embj.201490147.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu W, Dong J, Zheng Y, Zhou J, Yuan Y, Ta HM, et al. Immune-checkpoint protein VISTA regulates antitumor immunity by controlling myeloid cell-mediated inflammation and immunosuppression. Cancer Immunol Res. 2019;7(9):1497–510. https://doi.org/10.1158/2326-6066.CIR-18-0489.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell. 2009;16(3):183–94. https://doi.org/10.1016/j.ccr.2009.06.017.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spiegel A, Brooks MW, Houshyar S, Reinhardt F, Ardolino M, Fessler E, et al. Neutrophils suppress intraluminal NK cell-mediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells. Cancer Discov. 2016;6(6):630–49. https://doi.org/10.1158/2159-8290.CD-15-1157.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mishalian I, Bayuh R, Eruslanov E, Michaeli J, Levy L, Zolotarov L, et al. Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17—a new mechanism of impaired antitumor immunity. Int J Cancer. 2014;135(5):1178–86. https://doi.org/10.1002/ijc.28770.

Article  CAS  PubMed  Google Scholar 

Tyagi A, Sharma S, Wu K, Wu SY, Xing F, Liu Y, et al. Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung. Nat Commun. 2021;12(1):474. https://doi.org/10.1038/s41467-020-20733-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singhal S, Bhojnagarwala PS, O’Brien S, Moon EK, Garfall AL, Rao AS, Quatromoni JG, et al. Origin and role of a subset of tumor-associated neutrophils with antigen-presenting cell features in early-stage human lung cancer. Cancer Cell. 2016;30(1):120–35. https://doi.org/10.1016/j.ccell.2016.06.001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gershkovitz M, Caspi Y, Fainsod-Levi T, Katz B, Michaeli J, Khawaled S, et al. TRPM2 mediates neutrophil killing of disseminated tumor cells. Cancer Res. 2018;78(10):2680–90. https://doi.org/10.1158/0008-5472.CAN-17-3614.

Article  CAS  PubMed  Google Scholar 

Massara M, Bonavita O, Savino B, Caronni N, Mollica Poeta V, Sironi M, et al. ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activity. Nat Commun. 2018;9(1):676. https://doi.org/10.1038/s41467-018-03080-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, et al. Neutrophils kill antibody-opsonized cancer cells by trogoptosis. Cell Rep. 2018;23(13):3946-3959.e6. https://doi.org/10.1016/j.celrep.2018.05.082.

Article  CAS  PubMed  Google Scholar 

He M, Peng A, Huang XZ, Shi DC, Wang JC, Zhao Q, et al. Peritumoral stromal neutrophils are essential for c-Met-elicited metastasis in human hepatocellular carcinoma. Oncoimmunology. 2016;5(10): e1219828. https://doi.org/10.1080/2162402X.2016.1219828.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Demers M, Wagner DD. NETosis: a new factor in tumor progression and cancer-associated thrombosis. Semin Thromb Hemost. 2014;40(3):277–83. https://doi.org/10.1055/s-0034-1370765.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sagiv JY, Michaeli J, Assi S, Mishalian I, Kisos H, et al. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep. 2015;10(4):562–73. https://doi.org/10.1016/j.celrep.2014.12.039.

Article  CAS  PubMed  Google Scholar 

Pylaeva E, Lang S, Jablonska J. The essential role of type I interferons in differentiation and activation of tumor-associated neutrophils. Front Immunol. 2016;7:629. https://doi.org/10.3389/fimmu.2016.00629.